Global Neuroblastoma Drugs Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17715992 | Publishing Date : 18-Mar-2021
Detailed TOC of Global Neuroblastoma Drugs Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroblastoma Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuroblastoma Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroblastoma Drugs Market Perspective (2016-2027)
2.2 Neuroblastoma Drugs Growth Trends by Regions
2.2.1 Neuroblastoma Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuroblastoma Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Neuroblastoma Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Neuroblastoma Drugs Industry Dynamic
2.3.1 Neuroblastoma Drugs Market Trends
2.3.2 Neuroblastoma Drugs Market Drivers
2.3.3 Neuroblastoma Drugs Market Challenges
2.3.4 Neuroblastoma Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroblastoma Drugs Players by Revenue
3.1.1 Global Top Neuroblastoma Drugs Players by Revenue (2016-2021)
3.1.2 Global Neuroblastoma Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Neuroblastoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroblastoma Drugs Revenue
3.4 Global Neuroblastoma Drugs Market Concentration Ratio
3.4.1 Global Neuroblastoma Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Drugs Revenue in 2020
3.5 Neuroblastoma Drugs Key Players Head office and Area Served
3.6 Key Players Neuroblastoma Drugs Product Solution and Service
3.7 Date of Enter into Neuroblastoma Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroblastoma Drugs Breakdown Data by Type
4.1 Global Neuroblastoma Drugs Historic Market Size by Type (2016-2021)
4.2 Global Neuroblastoma Drugs Forecasted Market Size by Type (2022-2027)
5 Neuroblastoma Drugs Breakdown Data by Application
5.1 Global Neuroblastoma Drugs Historic Market Size by Application (2016-2021)
5.2 Global Neuroblastoma Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neuroblastoma Drugs Market Size (2016-2027)
6.2 North America Neuroblastoma Drugs Market Size by Type
6.2.1 North America Neuroblastoma Drugs Market Size by Type (2016-2021)
6.2.2 North America Neuroblastoma Drugs Market Size by Type (2022-2027)
6.2.3 North America Neuroblastoma Drugs Market Size by Type (2016-2027)
6.3 North America Neuroblastoma Drugs Market Size by Application
6.3.1 North America Neuroblastoma Drugs Market Size by Application (2016-2021)
6.3.2 North America Neuroblastoma Drugs Market Size by Application (2022-2027)
6.3.3 North America Neuroblastoma Drugs Market Size by Application (2016-2027)
6.4 North America Neuroblastoma Drugs Market Size by Country
6.4.1 North America Neuroblastoma Drugs Market Size by Country (2016-2021)
6.4.2 North America Neuroblastoma Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neuroblastoma Drugs Market Size (2016-2027)
7.2 Europe Neuroblastoma Drugs Market Size by Type
7.2.1 Europe Neuroblastoma Drugs Market Size by Type (2016-2021)
7.2.2 Europe Neuroblastoma Drugs Market Size by Type (2022-2027)
7.2.3 Europe Neuroblastoma Drugs Market Size by Type (2016-2027)
7.3 Europe Neuroblastoma Drugs Market Size by Application
7.3.1 Europe Neuroblastoma Drugs Market Size by Application (2016-2021)
7.3.2 Europe Neuroblastoma Drugs Market Size by Application (2022-2027)
7.3.3 Europe Neuroblastoma Drugs Market Size by Application (2016-2027)
7.4 Europe Neuroblastoma Drugs Market Size by Country
7.4.1 Europe Neuroblastoma Drugs Market Size by Country (2016-2021)
7.4.2 Europe Neuroblastoma Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Drugs Market Size (2016-2027)
8.2 Asia-Pacific Neuroblastoma Drugs Market Size by Type
8.2.1 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuroblastoma Drugs Market Size by Application
8.3.1 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuroblastoma Drugs Market Size by Region
8.4.1 Asia-Pacific Neuroblastoma Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuroblastoma Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuroblastoma Drugs Market Size (2016-2027)
9.2 Latin America Neuroblastoma Drugs Market Size by Type
9.2.1 Latin America Neuroblastoma Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Neuroblastoma Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Neuroblastoma Drugs Market Size by Type (2016-2027)
9.3 Latin America Neuroblastoma Drugs Market Size by Application
9.3.1 Latin America Neuroblastoma Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Neuroblastoma Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Neuroblastoma Drugs Market Size by Application (2016-2027)
9.4 Latin America Neuroblastoma Drugs Market Size by Country
9.4.1 Latin America Neuroblastoma Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Neuroblastoma Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Drugs Market Size (2016-2027)
10.2 Middle East & Africa Neuroblastoma Drugs Market Size by Type
10.2.1 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuroblastoma Drugs Market Size by Application
10.3.1 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuroblastoma Drugs Market Size by Country
10.4.1 Middle East & Africa Neuroblastoma Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuroblastoma Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuroblastoma Drugs Introduction
11.1.4 Pfizer Revenue in Neuroblastoma Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Neuroblastoma Drugs Introduction
11.2.4 Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Neuroblastoma Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 United Therapeutics
11.5.1 United Therapeutics Company Details
11.5.2 United Therapeutics Business Overview
11.5.3 United Therapeutics Neuroblastoma Drugs Introduction
11.5.4 United Therapeutics Revenue in Neuroblastoma Drugs Business (2016-2021)
11.5.5 United Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Neuroblastoma Drugs Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Neuroblastoma Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Others
Table 5. Global Neuroblastoma Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neuroblastoma Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Neuroblastoma Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Neuroblastoma Drugs Market Share by Regions (2016-2021)
Table 9. Global Neuroblastoma Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Neuroblastoma Drugs Market Share by Regions (2022-2027)
Table 11. Neuroblastoma Drugs Market Trends
Table 12. Neuroblastoma Drugs Market Drivers
Table 13. Neuroblastoma Drugs Market Challenges
Table 14. Neuroblastoma Drugs Market Restraints
Table 15. Global Neuroblastoma Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Neuroblastoma Drugs Market Share by Players (2016-2021)
Table 17. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2020)
Table 18. Ranking of Global Top Neuroblastoma Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Neuroblastoma Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Neuroblastoma Drugs Product Solution and Service
Table 22. Date of Enter into Neuroblastoma Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Neuroblastoma Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Neuroblastoma Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Neuroblastoma Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Neuroblastoma Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Neuroblastoma Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Neuroblastoma Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Neuroblastoma Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neuroblastoma Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Neuroblastoma Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Neuroblastoma Drugs Product
Table 65. Pfizer Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Teva Pharmaceutical Company Details
Table 68. Teva Pharmaceutical Business Overview
Table 69. Teva Pharmaceutical Neuroblastoma Drugs Product
Table 70. Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million)
Table 71. Teva Pharmaceutical Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Neuroblastoma Drugs Product
Table 75. Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Neuroblastoma Drugs Product
Table 80. Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. United Therapeutics Company Details
Table 83. United Therapeutics Business Overview
Table 84. United Therapeutics Neuroblastoma Drugs Product
Table 85. United Therapeutics Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million)
Table 86. United Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Others Features
Figure 5. Global Neuroblastoma Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Neuroblastoma Drugs Report Years Considered
Figure 10. Global Neuroblastoma Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Neuroblastoma Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Neuroblastoma Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Neuroblastoma Drugs Market Share by Regions (2022-2027)
Figure 14. Global Neuroblastoma Drugs Market Share by Players in 2020
Figure 15. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Neuroblastoma Drugs Revenue in 2020
Figure 17. Global Neuroblastoma Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Neuroblastoma Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Neuroblastoma Drugs Market Share by Type (2016-2027)
Figure 21. North America Neuroblastoma Drugs Market Share by Application (2016-2027)
Figure 22. North America Neuroblastoma Drugs Market Share by Country (2016-2027)
Figure 23. United States Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Neuroblastoma Drugs Market Share by Type (2016-2027)
Figure 27. Europe Neuroblastoma Drugs Market Share by Application (2016-2027)
Figure 28. Europe Neuroblastoma Drugs Market Share by Country (2016-2027)
Figure 29. Germany Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Neuroblastoma Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Neuroblastoma Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Neuroblastoma Drugs Market Share by Region (2016-2027)
Figure 39. China Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Neuroblastoma Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Neuroblastoma Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Neuroblastoma Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Neuroblastoma Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Neuroblastoma Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Neuroblastoma Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021)
Figure 62. United Therapeutics Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Keyplayers in Global Neuroblastoma Drugs Market Size, Status and Forecast 2021-2027
PfizerTeva Pharmaceutical
Johnson & Johnson
Bristol-Myers Squibb
United Therapeutics